E.Merge Technology Acquisition Corp. (NASDAQ: ETAC) announced this afternoon that it intends to dissolve and liquidate its trust due to its inability to complete a business combination.
The SPAC anticipates that the public shares will cease trading as of the close of business on September 4, 2022, and will redeem all of its outstanding shares from its IPO for approximately $10.06 per share.
E.Merge Technology, which priced an upsized IPO of $522 million over two years ago in July 2020, which grew to $600 million with its over-allotment, intended to find a target in the software and internet technology industries. The liquidation comes as a surprise as the SPAC’s sponsor recently contributed to its trust to extend its transaction timeline from August 4, 2022 to November 4, 2022.
ETAC marks the 18th SPAC liquidation so far in 2022, and the 5th in August thus far. The tech-focused SPAC was led by Jeff Clarke, as Co-Chief Executive Officer, Chief Financial Officer and Director, and Guy Gecht, as Co-Chief Executive Officer. S. Steven Singh will be Chairman of the Board of Directors.


Vendome Acquisition Corporation I (NASDAQ:VNMEU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “VNMEU”, Wednesday, July 2, 2025. The new SPAC plans to focus its search on target business in the consumer sector operating in North America, Southeast Asia, and Europe....
Origin Investment Corp. I (NASDAQ:ORIQU) announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ORIQU”, Wednesday, July 2, 2025. The new SPAC aims to mount a broad search for a target with a strong management and both revenue and earnings growth potential....
1RT Acquisition Corp. (NASDAQ:ONCHU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ONCHU”, Wednesday, July 2, 2025. The new SPAC plans to target company in the digital asset ecosystem involved in the creation, storage, exchange or management of such assets, whether...
D. Boral ARC Acquisition II Corp. (NASDAQ:ARBCU) has filed for a $250 million SPAC to give underwriter D. Boral a second in-house SPAC to pursue deals with. The new SPAC offers investors a 1/2 warrant and an initial 18-month time frame to complete a deal. D. Boral II’s sponsor may automatically extend this once by...
Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...